Valuation
- Market cap
- 475,000
- Revenue TTM
- $15,230,000
- Net income TTM
- $-28,760,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -188.84%
- Debt to equity
- 0.00
Trading
- Volume
- 400
- Avg volume
- 3,238
- Day's range
- $0.02 – $0.02
- Shares out
- 1,001,000
- Stochastic %K
- 0%
- Beta
- -0.09
- Analysts
- Strong Buy
- Price target
- $5.50
Company profile
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior c...
Show more
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 508 647 4000
- Website
- https://www.allurion.com
- Address
- 11 Huron Drive, Natick, United States
Latest news
No headlines yet.
